Barclays Capital Reiterates Overweight (N/A) on Philip Morris (PM)
Other equities research analysts have also recently issued reports about the stock. Analysts at Nomura (NYSE: NMR) reiterated a “reduce” rating on shares of Philip Morris in a research note to investors on Monday, May 14th. Separately, analysts at Bank of America (NYSE: BAC) reiterated a “buy” rating on shares of Philip Morris in a research note to investors on Monday, May 7th. They now have a $99.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Philip Morris in a research note to investors on Friday, April 20th. They now have a $91.00 price target on the stock.
Philip Morris opened at 81.20 on Monday. Philip Morris has a 52-week low of $60.45 and a 52-week high of $91.05. The company has a market cap of $138.5 billion and a price-to-earnings ratio of 16.25.
Philip Morris last released its earnings data on Thursday, April 19th. The company reported $1.25 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.20 by $0.05. Philip Morris’s revenue was up 9.7% compared to the same quarter last year. Analysts expect that Philip Morris will post $1.42 EPS next quarter.
Philip Morris International Inc. (PMI) is a holding company. PMI, through its subsidiaries and affiliates and their licensees, is engaged in the manufacture and sale of cigarettes and other tobacco products in markets outside of the United States of America.